ReviewApoptosis : an international journal on programmed cell death2026
The IAP family member BRUCE/BIRC6: an emerging new player in balancing life and death.
Review in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cell survival and death are the fundamental biological processes of life that involve both intracellular and extracellular dynamic events. How cells balance survival and death determines cell fate, and this question has attracted extensive research interest for decades yet remains largely unresolved. This review focuses on BRUCE, the only essential inhibitor-of-apoptosis (IAP) protein for survival. Based on recent structural discoveries regarding the autophagy-apoptosis switch, we provide novel mechanistic insights into this long-standing scientific question. BRUCE possesses a distinctive structure: its C-terminal UBC domain confers Ub conjugase (E2) and Ub-protein ligase (E3) activities, while its N-terminal region contains a baculoviral IAP repeat (BIR) domain. Benefiting from such distinctive structural properties. BRUCE centrally governs cell fate by modulating the transition from autophagy to apoptosis and maintaining genomic stability. At the organismal level, BRUCE sustains the homeostasis of reproductive and developmental processes by either inhibiting apoptosis or mediating substrate degradation. Aberrant BRUCE upregulation is widely implicated in diverse pathologies, including neurodevelopmental disorders and multiple malignancies. Nevertheless, research focusing on the targeted inhibition of BRUCE remains largely underexplored. A better understanding of the structural features and functional mechanisms of BRUCE will help elucidate how it exerts its pathogenic effects via regulation of cell survival and death. Such insights will lay a solid foundation for the future discovery and therapeutic application of specific BRUCE-targeted inhibitors. Outlooks and perspectives on the associated challenges are provided as well.
Indexed as
Identifiers
42149298What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.